Surgical lung biopsy is a pivotal procedure in cancer research, crucial for diagnosing and understanding lung cancers. By obtaining tissue samples directly from the lung, clinicians can analyze the cancer's genetic makeup, cellular structure, and behavior, aiding in personalized treatment strategies. This biopsy method allows for precise classification of lung cancer subtypes, guiding targeted therapies and prognostic predictions. Moreover, it facilitates research into novel biomarkers and therapeutic targets, advancing the frontier of cancer treatment. Despite its invasive nature, surgical lung biopsy remains indispensable for unraveling the complexities of lung cancer biology and improving patient outcomes through tailored interventions.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States